Rachel Hollander delivers strategic health policy and market access insights to clients across the healthcare and life sciences sector, with deep experience in Medicare coding, coverage, and reimbursement. She particularly focuses her work on the development, valuation, and pricing of medical services and technologies and on integrating those services into Medicare payment systems and broader coverage frameworks.
Rachel has significant experience in pricing and reimbursement for physician services, including rate-setting methodologies under the Medicare Physician Fee Schedule and Inpatient and Outpatient Prospective Payment Systems. She regularly advises on access and payment strategies for innovative medical technologies, including digital health tools and novel medical devices.
Rachel works closely with a diverse range of clients, including national medical specialty societies, trade associations, physician practices, and medical device manufacturers, to navigate complex regulatory processes and advance their market access and reimbursement goals. Her work includes representing clients before the American Medical Association (AMA) Current Procedural Terminology© Editorial Panel and Relative Value Scale Update Committee, leading the preparation and submission of code change applications, coordinating physician surveys for valuation, and guiding clients through each stage of AMA and Centers for Medicare & Medicaid Services processes.
Additionally, Rachel brings a strong foundation in data analysis, using Medicare claims data to inform coding strategies, assess market dynamics, and support evidence-based policies and reimbursement advocacy. She integrates this analytical perspective across all aspects of her policy, payment, and market access work.
Prior to joining McDermott+, Rachel was a consultant at national healthcare research and consulting firms, where her work included research and analysis focused on hospital and health system strategy, provider economics, and healthcare delivery system transformation.
